- Type / Class
- Equity / Common Stock
- Shares outstanding
- 164,426,217
- Total 13F shares
- 46,679,856
- Share change
- -562,534
- Total reported value
- $320,706,640
- Price per share
- $6.87
- Number of holders
- 87
- Value change
- -$8,056,035
- Number of buys
- 34
- Number of sells
- 39
Quarterly Holders Quick Answers
What is CUSIP 26818M108?
CUSIP 26818M108 identifies DYN - Dyne Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 26818M108:
Top shareholders of DYN - Dyne Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC |
13F
|
Company |
5.4%
|
8,934,902
|
$86,132,000 | — | 31 Mar 2022 | |
| MPM ASSET MANAGEMENT LLC |
13F
|
Company |
3%
|
4,951,303
|
$47,731,000 | — | 31 Mar 2022 | |
| Deep Track Capital, LP |
13F
|
Company |
2.1%
|
3,500,000
|
$33,740,000 | — | 31 Mar 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.8%
|
2,962,333
|
$28,557,000 | — | 31 Mar 2022 | |
| Vida Ventures Advisors, LLC |
13F
|
Company |
1.8%
|
2,960,046
|
$28,535,000 | — | 31 Mar 2022 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
1.7%
|
2,805,045
|
$27,041,000 | — | 31 Mar 2022 | |
| Logos Global Management LP |
13F
|
Company |
1.7%
|
2,734,392
|
$26,360,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.4%
|
2,364,981
|
$22,797,000 | — | 31 Mar 2022 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.1%
|
1,887,900
|
$18,199,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.85%
|
1,393,941
|
$13,437,000 | — | 31 Mar 2022 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.72%
|
1,182,706
|
$11,386,000 | — | 31 Mar 2022 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.72%
|
1,177,948
|
$11,355,000 | — | 31 Mar 2022 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
0.61%
|
1,000,000
|
$9,640,000 | — | 31 Mar 2022 | |
| Woodline Partners LP |
13F
|
Company |
0.49%
|
813,139
|
$7,839,000 | — | 31 Mar 2022 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.46%
|
750,000
|
$7,230,000 | — | 31 Mar 2022 | |
| NORGES BANK |
13F
|
Company |
0.36%
|
600,000
|
$5,784,000 | — | 31 Mar 2022 | |
| Vivo Capital, LLC |
13F
|
Company |
0.35%
|
577,642
|
$5,568,000 | — | 31 Mar 2022 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.32%
|
525,284
|
$5,064,000 | — | 31 Mar 2022 | |
| Artal Group S.A. |
13F
|
Company |
0.32%
|
525,000
|
$5,061,000 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.3%
|
500,971
|
$4,829,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.3%
|
488,802
|
$4,712,000 | — | 31 Mar 2022 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.21%
|
349,279
|
$3,367,000 | — | 31 Mar 2022 | |
| S.c.a. Candriam |
13F
|
Individual |
0.2%
|
323,393
|
$3,117,000 | — | 31 Mar 2022 | |
| Commodore Capital LP |
13F
|
Company |
0.19%
|
305,125
|
$2,941,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.19%
|
304,528
|
$2,935,000 | — | 31 Mar 2022 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.18%
|
295,229
|
$2,846,000 | — | 31 Mar 2022 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.17%
|
279,704
|
$2,696,000 | — | 31 Mar 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.16%
|
256,664
|
$2,474,000 | — | 31 Mar 2022 | |
| EcoR1 Capital, LLC |
13F
|
Company |
0.13%
|
215,000
|
$2,073,000 | — | 31 Mar 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.12%
|
192,477
|
$1,856,000 | — | 31 Mar 2022 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.11%
|
183,300
|
$1,767,000 | — | 31 Mar 2022 | |
| HighVista Strategies LLC |
13F
|
Company |
0.1%
|
168,691
|
$1,626,000 | — | 31 Mar 2022 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
0.1%
|
168,500
|
$1,624,000 | — | 31 Mar 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.09%
|
142,825
|
$1,284,000 | — | 31 Mar 2022 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.29%
|
476,000
|
$1,158,000 | — | 31 Mar 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.07%
|
112,087
|
$1,081,000 | — | 31 Mar 2022 | |
| HARVARD MANAGEMENT CO INC |
13F
|
Company |
0.07%
|
107,252
|
$1,034,000 | — | 31 Mar 2022 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.06%
|
95,113
|
$917,000 | — | 31 Mar 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.05%
|
78,557
|
$757,000 | — | 31 Mar 2022 | |
| FMR LLC |
13F
|
Company |
0.04%
|
72,767
|
$701,000 | — | 31 Mar 2022 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.03%
|
55,131
|
$531,000 | — | 31 Mar 2022 | |
| Swiss National Bank |
13F
|
Company |
0.03%
|
54,900
|
$529,000 | — | 31 Mar 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.03%
|
50,278
|
$484,000 | — | 31 Mar 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.03%
|
48,500
|
$468,000 | — | 31 Mar 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.03%
|
42,700
|
$412,000 | — | 31 Mar 2022 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.02%
|
40,000
|
$386,000 | — | 31 Mar 2022 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.02%
|
38,900
|
$375,000 | — | 31 Mar 2022 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.02%
|
37,921
|
$366,000 | — | 31 Mar 2022 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.02%
|
37,444
|
$361,000 | — | 31 Mar 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.02%
|
36,458
|
$351,000 | — | 31 Mar 2022 |
Institutional Holders of Dyne Therapeutics, Inc. - Common Stock (DYN) as of Q2 2022
As of 30 Jun 2022,
Dyne Therapeutics, Inc. - Common Stock (DYN) was held by
87 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,679,856 shares.
The largest 10 holders included
Atlas Venture Life Science Advisors, LLC, MPM ASSET MANAGEMENT LLC, Deep Track Capital, LP, Vida Ventures Advisors, LLC, CITADEL ADVISORS LLC, Logos Global Management LP, RA CAPITAL MANAGEMENT, L.P., BlackRock Inc., FRANKLIN RESOURCES INC, and Point72 Asset Management, L.P..
This page lists
87
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
90
Q2 2022 holders
87
Holder diff
-3
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.